Selection of antigenic variants in maedi-visna virus infection

Journal of General Virology

Volumn 83, Issue 10, 2002, Pages 2543-2551

  Andrésdóttir, Valgerdur ^a   Skraban, Robert ^a   Matthíasdóttir, Sigrídur ^a   Lutley, Roger ^a   Agnarsdóttir, Gudrún ^a   Thorsteinsdóttir, Hólmfrídur ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN PURIFICATION; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; POINT MUTATION; PRIORITY JOURNAL; SERUM; SHEEP; VIRUS GENE; VIRUS INFECTION; VIRUS MUTANT; VIRUS NEUTRALIZATION; VISNA VIRUS;

ANIMALIA; DNA VIRUSES; MAEDI-VISNA VIRUS; OVIS ARIES; RNA VIRUSES; VISNA VIRUS;

EID: 0036788431     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-10-2543     Document Type: Article

References (46)

1. Agnarsdóttir, G., Thorsteinsdóttir, H., Óskarsson, T., Matthíasdóttir, S., Haflidadóttir, B. S., Andrésson, Ó. S. & Andrésdóttir, V. (2000). The long terminal repeat is a determinant of cell tropism of maedi-visna virus. Journal of General Virology 81, 1901-1905.
2. Andrésdóttir, V., Tang, X., Agnarsdóttir, G., Andrésson, Ó. S., Georgsson, G., Skraban, R., Torsteinsdóttir, S., Rafnar, B., Benediktsdóttir, E., Matthíasdóttir, S., Árnadóttir, S., Högnadóttir, S., Pálsson, P. A. & Pétursson, G. (1998). Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus. Virus Genes 16, 281-293.
3. Andrésson, Ó. S., Elser, J. E., Tobin, G. J., Greenwood, J. D., Gonda, M. A., Georgsson, G., Andrésdóttir, V., Benediktsdóttir, E., Carisdóttir, H. M., Mantyla, E. O., Rafnar, B., Pálsson, P. A., Casey, J. W. & Pétursson, G. (1993). Nucleotide sequence and biological properties of pathogenic proviral molecular clone of neurovirulent visna virus. Virology 193, 89-105.
4. Back, N. K. T., Smit, L., de Jong, J.-J., Keulen, W., Schutten, M., Goudsmit, J. & Tersmette, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
5. Braun, M. J., Clements, J. E. & Gonda, M. A. (1987). The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. Journal of Virology 61, 4046-4054.
6. Burns, D. P. W., Collignon, C. & Desrosiers, R. C. (1993). Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. Journal of Virology 67, 4104-4113.
7. Cheevers, W. P., Cordery-Cotter, R., McGuire, T. C. & DeMartini, J. C. (1999). Neutralizing antibody responses and evolution of antigenic variants in monozygotic twin lambs infected with phenotypically distinct ovine lentiviruses. Virology 258, 382-388.
8. Choi, W. S., Collignon, C., Thiriart, C., Burns, D. P. W., Stott, E. J., Kent, K. A. & Desrosiers, R. C. (1994). Effects of natural sequence variation on recognition by monoclonal antibodies that neutralize simian immunodeficiency virus infectivity. Journal of Virology 68, 5395-5402.
9. Clements, J. E., Montelaro, R. C., Zink, M. C., Amedee, A. M., Miller, S., Trichel, A. M., Jagerski, B., Hauer, D., Martin, L. N., Bohm, R. P. & Murphey-Corb, M. (1995). Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. Journal of Virology 69, 2737-2744.
10. Domingo, E., Díez, J., Martínez, M. A., Hernández, J., Holguín, A., Borrego, B. & Mateu, M. G. (1993). New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. Journal of General Virology 74, 2039-2045.
11. Dubois-Dalq, M., Narayan, O. & Griffin, D. E. (1979). Cell surface changes associated with mutation of visna virus in antibody-treated cell cultures. Virology 92, 353-366.
12. Ellis, T. M., Wilcox, G. E. & Robinson, W. F. (1987). Antigenic variation of caprine arthritis encephalitis virus during persistent infection of goals. Journal of General Virology 68, 3145-3152.
13. Gendelman, H. E., Narayan, O., Kennedy-Stoskopf, S., Kennedy, P. G. E., Ghotbi, Z., Clements, J. E., Stanley, J. & Pezeshkpour, G. (1986). Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. Journal of Virology 58, 67-74.
14. Georgsson, G., Torsteinsdóttir, S., Pétursson, G., Pálsson, P. A. & Andrésson, Ó. S. (1993). Role of the immune response in visna, a lentiviral central nervous system disease of sheep. In Animal models of HIV and other retroviral infections, pp. 183-195. Edited by P. Racz, N. L. Levtin & J. C. Gluckman. Basel: Karger.
15. Griffin, D. E., Narayan, O. & Adams, R. J. (1978). Early immune responses in visna, a slow disease of sheep. Journal of Infectious Diseases 138, 340-350.
16. Gudnadóttir, M. (1974). Visna-maedi in sheep. Progress in Medical Virology 18, 336-349.
17. Javaherian, K., Langlois, A. J., Montefiori, D. C., Kent, K. A., Ryan, K. A., Wyman, P. D., Stott, J., Bolognesi, D. P., Murphey-Corb, M. & Larosa, G. J. (1994). Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. Journal of Virology 68, 2624-2631.
18. Kono, Y., Kobayashi, K. & Fukunaga, Y. (1973). Antigenic drift of equine infectious anemia virus in chronically infected horses. Archiv für die gesamte Virusforschung 41, 1-10.
19. Larsen, H. J., Hyllseth, B. & Krogsrud, J. (1982). Experimental maedi virus infection in sheep: early cellular and humoral immune response during three years following parenteral inoculation. American Journal of Veterinary Research 43, 379-383.
20. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N. & Gregory, T. J. (1990). Assignment of intrachain disulficle bonds and characterization of potential glycosylation sites of the type 1 recombinant HIV envelope glycoprolein (gp120) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry 265, 10373-10382.
21. Li, W.-H., Wu, C.-I. & Luo, C.-C. (1985). A new method for estimating synonymous and nonsynonymous rates of nucleolide substitution considering the relative likelihood of nucleolide and codon changes. Molecular Biology and Evolution 2, 150-174.
22. Li, Y., Luo, L., Rasool, N. & Kang, C. Y. (1993). Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. Journal of Virology 67, 584-588.
23. Lutley, R., Pétursson, G., Pálsson, P. A., Georgsson, G., Klein, J. & Nathanson, N. (1983). Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. Journal of General Virology 64, 1433-1440.
24. McGuire, T. C., Norton, L. K., O'Rourke, K. I. & Cheevers, W. P. (1988). Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis. Journal of Virology 62, 3488-3492.
25. McKeating, J. A., Gow, J., Goudsmit, J., Pearl, L. H., Mulder, C. & Weiss, R. A. (1989). Characterization of HIV-1 neutralization escape mutants. AIDS 3, 777-784.
26. McKnight, A., Weiss, R. A., Shotton, C., Takeuchi, Y., Hoshino, H. & Clapham, P. R. (1995). Change in tropism upon immune escape by human immunodeficiency virus. Journal of Virology 69, 3167-3170.
27. Montelaro, R. C., Perekh, B., Orrego, A. & Issel, C. J. (1984). Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. Journal of Biological Chemistry 259, 10539-10544.
28. Narayan, O., Griffin, D. E. & Chase, J. (1977). Antigenic shift of visna virus in persistently infected sheep. Science 197, 376-378.
29. Pétursson, G., Nathanson, N., Georgsson, G., Panitch, H. & Pálsson, P.A. (1976). Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Laboratory Investigation 35, 402-412.
30. Reitter, J. N., Means, R. E. & Desrosiers, R. C. (1998). A role for carbohydrates in immune evasion in AIDS. Nature Medicine 4, 679-684.
31. Sargan, D. R., Bennet, I. D., Cousens, C., Roy, D. J., Blacklaws, B. A., Dalziel, R. G., Watt, N. J. & McConnell, I. (1991). Nucleotide sequence of EV1, a British isolate of maedi-visna virus. Journal of General Virology 72, 1893-1903.
32. Schønning, K., Jansson, B., Olofsson, S., Nielsen, J. O. & Hansen, J.-E. S. (1996). Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology 218, 134-140.
33. Siebelink, K. H. J., Rimmelzwaan, G. F., Bosch, M. L., Meloen, R. H. & Osterhaus, A. D. M. E. (1993). A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. Journal of Virology 67, 2202-2208.
34. Sigurdsson, B. & Pálsson, P. A. (1958). Visna of sheep. A slow demyelinating infection. British Journal of Experimental Pathology 39, 519-528.
35. Sigurdsson, B., Thormar, H. & Pálsson, P. A. (1960). Cultivation of visna virus in [issue culture. Archiv für die gesamte Virusforschung 10, 368-380.
36. Sihvonen, L. (1981). Early immune responses in experimental maedi. Research in Veterinary Science 30, 217-222.
37. Skraban, R., Matthíasdóttir, S., Torsteinsdóttir, S., Agnarsdóttir, G., Gudmundsson, B., Georgsson, G., Meloen, R. H., Andrésson, Ó. S., Staskus, K. A., Thormar, H. & Andrésdóttir, V. (1999). Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype. Journal of Virology 73, 8064-8072.
38. Sonigo, P., Alizon, M., Staskus, K., Klatzmann, D., Cole, S., Danos, O., Retzel, E. & Wain-Hobson, S. (1985). Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell 42, 369-382.
39. Thormar, H. & Helgadóttir, H. (1965). A comparison of visna and maedi viruses. II. Serological relationship. Research in Veterinary Science 6, 456-465.
40. Thormar, H., Barshatzky, M. R., Arnesen, K. & Kozlowski, P. B. (1983). The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo. Journal of General Virology 64, 1427-1432.
41. Torsteinsdóttir, S., Georgsson, G., Gísladóttir, E., Rafnar, B., Pĺsson, P.A. & Pétursson, G. (1992). Pathogenesis of central nervous system lesions in visna: cell-mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid. Journal of Neuroimmunology 41, 149-158.
42. Valas, S., Benoit, C., Baudry, C., Perrin, G. & Mamoun, R. Z. (2000). Variability and immunogenicity of caprine arthritis-encephalitis virus surface glycoprotein. Journal of Virology 74, 6178-6185.
43. Wolfs, T. F. W., Zwart, G., Bakker, M., Valk, M., Kuiken, C. L. & Goudsmit, J. (1991). Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 185, 195-205.
44. Wolinsky, S. M., Korber, B. T. M., Neumann, A. U., Daniels, M., Kunstman, K. J., Whetsell, A. J., Furtado, M. R., Cao, Y., Ho, D. D., Safrit, J. T. & Koup, R. A. (1996). Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272, 537-541.
45. Yoshida, K., Nakamura, M. & Ohno, T. (1997). Mutations of the HIV type 1 V3 loop under selection pressure with neutralizing monoclonal antibody NM-01. AIDS Research and Human Retroviruses 13, 1283-1290.
46. Zhang, P. F., Chen, X., Fu, D. W., Margolick, J. B. & Quinnan, G. V., Jr (1999). Primary virus envelope cross-reactivity of the broadening neutralizing antibody response during early chronic human immunodeficiency virus type 1 infection. Journal of Virology 73, 5225-5230.